Concepedia

Publication | Open Access

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline

DOIFull Paper Access

25

Citations

20

References

2016

Year

Stefan Sturm, Anton Forsberg, Stephane Navé, Per Stenkrona, Nicholas Seneca, Andrea Varrone, Robert A. Comley, Patrik Fazio, Candice Jamois, Ryuji Nakao,
European Journal of Nuclear Medicine and Molecular Imaging

Abstract

This PET study confirmed that daily treatment of at least 1 mg sembragiline resulted in near-maximal inhibition of brain MAO-B enzyme in patients with AD.

References

YearCitations

Page 1